Immune checkpoint blockade therapy for esophageal squamous cell carcinoma

This publication has 17 references indexed in Scilit:

• Burden of Nonsynonymous Mutations among TCGA Cancers and Candidate Immune Checkpoint Inhibitor Responses
  Cancer Research, 2016
• Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer
  European Journal of Cancer, 2016
• Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations
  2015
• Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy
  The Lancet Oncology, 2015
• Classifying Cancers Based on T-cell Infiltration and PD-L1
  Cancer Research, 2015
• Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
  The Lancet Oncology, 2014
• Signatures of mutational processes in human cancer
  Nature, 2013
• Microsatellite instability and clinicopathological features in esophageal squamous cell cancer
  Oncology Reports, 2007
• Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
  Nature Medicine, 2002
• Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer
  Proceedings of the National Academy of Sciences, 2001